Antibiotic Treatment of Multiple Erythema Migrans

• Status: Unknown status
• Trial end date: 2017-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy and safety of 15-day ceftriaxone versus 15-day doxycycline treatment in patients with multiple erythema migrans.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Medical Centre Ljubljana
• Treatments: Ceftriaxone; Doxycycline

Criteria

Inclusion Criteria:

• multiple erythema migrans in patients > 15 years

Exclusion Criteria:

• a history of Lyme borreliosis in the past

• pregnancy or lactation

• immunocompromised status

• serious adverse event to doxycycline or beta lactam antibiotic

• taking antibiotic with antiborrelial activity within 10 days